文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

CD44+ 和 CD133+ 非小细胞肺癌细胞表现出与 p53 状态相关的 DNA 损伤反应途径和休眠多倍体巨癌细胞富集。

CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status.

机构信息

School of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141700 Dolgoprudny, Russia.

State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency (SRC-FMBC), 123098 Moscow, Russia.

出版信息

Int J Mol Sci. 2022 Apr 28;23(9):4922. doi: 10.3390/ijms23094922.


DOI:10.3390/ijms23094922
PMID:35563313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9101266/
Abstract

Cancer stem cells (CSCs) play a critical role in the initiation, progression and therapy relapse of many cancers including non-small cell lung cancer (NSCLC). Here, we aimed to address the question of whether the FACS-sorted CSC-like (CD44 + &CD133 +) vs. non-CSC (CD44-/CD133- isogenic subpopulations of p53wt A549 and p53null H1299 cells differ in terms of DNA-damage signaling and the appearance of "dormant" features, including polyploidy, which are early markers (predictors) of their sensitivity to genotoxic stress. X-ray irradiation (IR) at 5 Gy provoked significantly higher levels of the ATR-Chk1/Chk2-pathway activity in CD44-/CD133- and CD133+ subpopulations of H1299 cells compared to the respective subpopulations of A549 cells, which only excited ATR-Chk2 activation as demonstrated by the Multiplex DNA-Damage/Genotoxicity profiling. The CD44+ subpopulations did not demonstrate IR-induced activation of ATR, while significantly augmenting only Chk2 and Chk1/2 in the A549- and H1299-derived cells, respectively. Compared to the A549 cells, all the subpopulations of H1299 cells established an increased IR-induced expression of the γH2AX DNA-repair protein. The CD44-/CD133- and CD133+ subpopulations of the A549 cells revealed IR-induced activation of ATR-p53-p21 cell dormancy signaling-mediated pathway, while none of the CD44+ subpopulations of either cell line possessed any signs of such activity. Our data indicated, for the first time, the transcription factor MITF-FAM3C axis operative in p53-deficient H1299 cells, specifically their CD44+ and CD133+ populations, in response to IR, which warrants further investigation. The p21-mediated quiescence is likely the predominant surviving pathway in CD44-/CD133- and CD133+ populations of A549 cells as indicated by single-cell high-content imaging and analysis of Ki67- and EdU-coupled fluorescence after IR stress. SA-beta-galhistology revealed that cellular-stress-induced premature senescence (SIPS) likely has a significant influence on the temporary dormant state of H1299 cells. For the first time, we demonstrated polyploid giant and/or multinucleated cancer-cell (PGCC/MGCC) fractions mainly featuring the progressively augmenting Ki67 phenotype in CD44+ and CD133+ A549 cells at 24-48 h after IR. In contrast, the Ki67 phenotype enrichment in the same fractions of all the sorted H1299 cells suggested an increase in their cycling/heterochromatin reorganization activity after IR stress. Our results proposed that entering the "quiescence" state rather than p21-mediated SIPS may play a significant role in the survival of p53wt CSC-like NSCLC cells after IR. The results obtained are important for the selection of therapeutic schemes for the treatment of patients with NSCLC, depending on the functioning of the p53 system in tumor cells.

摘要

癌症干细胞 (CSCs) 在许多癌症的发生、进展和治疗复发中起着关键作用,包括非小细胞肺癌 (NSCLC)。在这里,我们旨在解决以下问题:p53wt A549 和 p53null H1299 细胞的 FACS 分选的 CSC 样(CD44 + 和 CD133 +)与非 CSC(CD44-/CD133-)同基因亚群在 DNA 损伤信号转导和“休眠”特征(包括多倍体,这是其对遗传毒性应激敏感性的早期标志物(预测因子))方面是否存在差异。X 射线照射 (IR) 5Gy 可显著增加 H1299 细胞的 CD44-/CD133- 和 CD133+ 亚群中 ATR-Chk1/Chk2 通路的活性,而 A549 细胞的相应亚群仅激活 ATR-Chk2 激活,如 Multiplex DNA-Damage/Genotoxicity profiling 所示。CD44+ 亚群未表现出 IR 诱导的 ATR 激活,而仅在 A549 和 H1299 衍生细胞中分别显著增加 Chk2 和 Chk1/2。与 A549 细胞相比,H1299 细胞的所有亚群均建立了增加的 IR 诱导的 γH2AX DNA 修复蛋白表达。A549 细胞的 CD44-/CD133- 和 CD133+ 亚群显示出 IR 诱导的 ATR-p53-p21 细胞休眠信号转导介导的途径的激活,而两种细胞系的任何 CD44+ 亚群均未显示出任何此类活性的迹象。我们的数据首次表明,在 p53 缺陷型 H1299 细胞中,特别是在其 CD44+和 CD133+ 群体中,存在转录因子 MITF-FAM3C 轴在 IR 下的作用,这值得进一步研究。p21 介导的静止很可能是 A549 细胞的 CD44-/CD133- 和 CD133+ 群体中的主要存活途径,如 IR 应激后单细胞高内涵成像和 Ki67-和 EdU 偶联荧光分析所示。SA-β-半乳糖组织化学显示,细胞应激诱导的过早衰老 (SIPS) 可能对 H1299 细胞的暂时休眠状态有重大影响。我们首次证明了多倍体巨细胞和/或多核癌细胞 (PGCC/MGCC) 亚群,其特征主要是在 IR 后 24-48 小时,在 CD44+和 CD133+ A549 细胞中 Ki67 表型逐渐增加。相比之下,在所有分选的 H1299 细胞的相同亚群中 Ki67 表型的富集表明在 IR 应激后它们的循环/异染色质重排活性增加。我们的结果表明,进入“静止”状态而不是 p21 介导的 SIPS 可能在 p53wt CSC 样 NSCLC 细胞在 IR 后存活中起重要作用。这些结果对于根据肿瘤细胞中 p53 系统的功能选择治疗 NSCLC 患者的治疗方案非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/6a94705c9bdf/ijms-23-04922-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/f45ead5216a8/ijms-23-04922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/836e81b40191/ijms-23-04922-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/7afed0b24b43/ijms-23-04922-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/a8e995075142/ijms-23-04922-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/8b031d0f83db/ijms-23-04922-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/aa3c31fe1677/ijms-23-04922-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/b13a9f701147/ijms-23-04922-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/c01efbd9ad22/ijms-23-04922-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/54dcb314c4a2/ijms-23-04922-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/6a94705c9bdf/ijms-23-04922-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/f45ead5216a8/ijms-23-04922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/836e81b40191/ijms-23-04922-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/7afed0b24b43/ijms-23-04922-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/a8e995075142/ijms-23-04922-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/8b031d0f83db/ijms-23-04922-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/aa3c31fe1677/ijms-23-04922-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/b13a9f701147/ijms-23-04922-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/c01efbd9ad22/ijms-23-04922-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/54dcb314c4a2/ijms-23-04922-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/6a94705c9bdf/ijms-23-04922-g010.jpg

相似文献

[1]
CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status.

Int J Mol Sci. 2022-4-28

[2]
The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.

Int J Mol Sci. 2021-2-27

[3]
The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.

Int J Mol Sci. 2020-5-8

[4]
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

PLoS One. 2010-11-19

[5]
CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.

Mol Carcinog. 2016-12

[6]
CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells.

Radiother Oncol. 2014-3

[7]
Polyploid/Multinucleated Giant and Slow-Cycling Cancer Cell Enrichment in Response to X-ray Irradiation of Human Glioblastoma Multiforme Cells Differing in Radioresistance and TP53/PTEN Status.

Int J Mol Sci. 2023-1-8

[8]
IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.

Radiat Oncol. 2015-11-14

[9]
Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.

PLoS One. 2013-1-17

[10]
CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549.

Cell Mol Biol Lett. 2014-3

引用本文的文献

[1]
Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence.

Front Oncol. 2025-6-6

[2]
Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma.

Oncol Res. 2025-2-28

[3]
Green silver nanoparticles curcumin conjugate induced photodynamic therapy of lung cancer and lung cancer stem cells.

RSC Adv. 2025-2-14

[4]
Loss of Fascin2 increases susceptibility to cisplatin-induced hearing impairment and cochlear cell apoptosis in mice.

J Otol. 2024-7

[5]
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.

J Biol Chem. 2024-12

[6]
TGM2-Mediated Autophagy Contributes to the Radio-Resistance of Non-Small Cell Lung Cancer Stem-like Cells.

Biomedicines. 2024-9-30

[7]
Post-translational modifications: The potential ways for killing cancer stem cells.

Heliyon. 2024-7-4

[8]
DNMT1/miR-152-3p/SOS1 signaling axis promotes self-renewal and tumor growth of cancer stem-like cells derived from non-small cell lung cancer.

Clin Epigenetics. 2024-4-15

[9]
MITF regulates the subcellular location of HIF1α through SUMOylation to promote the invasion and metastasis of daughter cells derived from polyploid giant cancer cells.

Oncol Rep. 2024-5

[10]
Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasis.

Clin Transl Med. 2024-2

本文引用的文献

[1]
Triple-negative expression (ALDH1A1-/CD133-/mutant p53-) cases in lung adenocarcinoma had a good prognosis.

Sci Rep. 2022-1-27

[2]
CD44: A Multifunctional Mediator of Cancer Progression.

Biomolecules. 2021-12-9

[3]
Evaluation of DNA double-strand break repair capacity in human cells: Critical overview of current functional methods.

Mutat Res Rev Mutat Res. 2021

[4]
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment.

Cell Rep. 2021-11-30

[5]
Recent advances in γH2AX biomarker-based genotoxicity assays: A marker of DNA damage and repair.

DNA Repair (Amst). 2021-12

[6]
When dormancy fuels tumour relapse.

Commun Biol. 2021-6-16

[7]
IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression.

Cancers (Basel). 2021-5-28

[8]
Different Stages of Quiescence, Senescence, and Cell Stress Identified by Molecular Algorithm Based on the Expression of Ki67, RPS6, and Beta-Galactosidase Activity.

Int J Mol Sci. 2021-3-18

[9]
The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.

Int J Mol Sci. 2021-2-27

[10]
: an emerging biomarker and potential therapeutic target for cancer.

Biomark Med. 2021-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索